Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis

BACKGROUND: Systemic juvenile idiopathic arthritis (SoJIA) is the most striking form of juvenile idiopathic arthritis. The aim of our study was to evaluate the clinical responses and outcomes of children with SoJIA to IL-6 blockade using two different tocilizumab (TCZ) treatment protocols designed f...

詳細記述

保存先:
書誌詳細
出版年:Pediatr Rheumatol Online J
主要な著者: Kostik, Mikhail M, Dubko, Margarita F, Masalova, Vera V, Snegireva, Ludmila S, Kornishina, Tatyana L, Chikova, Irina A, Isupova, Eugenia A, Kuchinskaya, Ekaterina M, Glebova, Natalia I, Buchinskaya, Natalia V, Kalashnikova, Olga V, Chasnyk, Vyacheslav G
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2015
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4328569/
https://ncbi.nlm.nih.gov/pubmed/25685108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-13-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料